|
1
|
Center MM and Jemal A: International
trends in liver cancer incidence rates. Cancer Epidemiol Biomarkers
Prev. 20:2362–2368. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Baek D, Villén J, Shin C, Camargo FD, Gygi
SP and Bartel DP: The impact of microRNAs on protein output.
Nature. 455:64–71. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ebert MS and Sharp PA: Roles for microRNAs
in conferring robustness to biological processes. Cell.
149:515–524. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
He H, Hao SJ, Yao L, Yang F, Di Y, Li J,
Jiang YJ, Jin C and Fu DL: MicroRNA-218 inhibits cell invasion and
migration of pancreatic cancer via regulating ROBO1. Cancer Biol
Ther. 15:1333–1339. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang X, Lv W, Zhang JH and Lu DL: miR-96
functions as a tumor suppressor gene by targeting NUAK1 in
pancreatic cancer. Int J Mol Med. 34:1599–1605. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li J, Kong F, Wu K, Song K, He J and Sun
W: miR-193b directly targets STMN1 and uPA genes and suppresses
tumor growth and metastasis in pancreatic cancer. Mol Med Rep.
10:2613–2620. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ahn SM, Cha JY, Kim J, Kim D, Trang HT,
Kim YM, Cho YH, Park D and Hong S: Smad3 regulates E-cadherin via
miRNA-200 pathway. Oncogene. 31:3051–3059. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu L, Li Y, Yan D, He J and Liu D:
MicroRNA-183 inhibits gastric cancer proliferation and invasion via
directly targeting Bmi-1. Oncol Lett. 8:2345–2351. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tang Y, Liu X, Su B, Zhang Z, Zeng X, Lei
Y, Shan J, Wu Y, Tang H and Su Q: microRNA-22 acts as a metastasis
suppressor by targeting metadherin in gastric cancer. Mol Med Rep.
11:454–460. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tang H, Liu P, Yang L and Xie X, Ye F, Wu
M, Liu X, Chen B, Zhang L and Xie X: miR-185 suppresses tumor
proliferation by directly targeting E2F6 and DNMT1 and indirectly
upregulating BRCA1 in triple-negative breast cancer. Mol Cancer
Ther. 13:3185–3197. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yan X, Chen X, Liang H, Deng T, Chen W,
Zhang S, Liu M, Gao X, Liu Y, Zhao C, et al: miR-143 and miR-145
synergistically regulate ERBB3 to suppress cell proliferation and
invasion in breast cancer. Mol Cancer. 13:2202014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen X, Wang X, Ruan A, Han W, Zhao Y, Lu
X, Xiao P, Shi H, Wang R, Chen L, et al: miR-141 is a key regulator
of renal cell carcinoma proliferation and metastasis by controlling
EphA2 expression. Clin Cancer Res. 20:2617–2630. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou X, Xia Y, Su J and Zhang G:
Down-regulation of miR-141 induced by helicobacter pylori
promotes the invasion of gastric cancer by targeting STAT4. Cell
Physiol Biochem. 33:1003–1012. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Du Y, Xu Y, Ding L, Yao H, Yu H, Zhou T
and Si J: Down-regulation of miR-141 in gastric cancer and its
involvement in cell growth. J Gastroenterol. 44:556–561. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mei Z, He Y, Feng J, Shi J, Du Y, Qian L,
Huang Q and Jie Z: MicroRNA-141 promotes the proliferation of
non-small cell lung cancer cells by regulating expression of PHLPP1
and PHLPP2. FEBS Lett. 588:3055–3061. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhao G, Wang B, Liu Y, Zhang JG, Deng SC,
Qin Q, Tian K, Li X, Zhu S, Niu Y, et al: miRNA-141, downregulated
in pancreatic cancer, inhibits cell proliferation and invasion by
directly targeting MAP4K4. Mol Cancer Ther. 12:2569–2580. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang XL, Xie HY, Zhu CD, Zhu XF, Cao GX,
Chen XH and Xu HF: Increased miR-141 expression is associated with
diagnosis and favorable prognosis of patients with bladder cancer.
Tumour Biol. 36:877–883. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xue J, Niu YF, Huang J, Peng G, Wang LX,
Yang YH and Li YQ: miR-141 suppresses the growth and metastasis of
HCC cells by targeting E2F3. Tumour Biol. 35:12103–12107. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu SM, Ai HW, Zhang DY, Han XQ, Pan Q, Luo
FL and Zhang XL: miR-141 targets ZEB2 to suppress HCC progression.
Tumour Biol. 35:9993–9997. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu Y, Ding Y, Huang J, Wang S, Ni W, Guan
J, Li Q, Zhang Y, Ding Y, Chen B, et al: miR-141 suppresses the
migration and invasion of HCC cells by targeting Tiam1. PLoS One.
9:e883932014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Goel A, Boland CR and Hur K: Changes in
the expression of mir-200c/141 cluster of micrornas as biomarkers
for epithelial- to-mesenchymal transition in human colorectal
cancer metastasis. World Intellectual Property Organization Patent
WO2012/128902Al. Filed February 29 2012; issued September 27
2012.
|
|
26
|
Bracken CP, Li X, Wright JA, Lawrence DM,
Pillman KA, Salmanidis M, Anderson MA, Dredge BK, Gregory PA,
Tsykin A, et al: Genome-wide identification of miR-200 targets
reveals a regulatory network controlling cell invasion. EMBO J.
33:2040–2056. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Roy SS, Gonugunta VK, Bandyopadhyay A, Rao
MK, Goodall GJ, Sun LZ, Tekmal RR and Vadlamudi RK: Significance of
PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of
breast cancer. Oncogene. 33:3707–3716. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Feng X, Wang Z, Fillmore R and Xi Y:
miR-200, a new star miRNA in human cancer. Cancer Lett.
344:166–173. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hung CS, Liu HH, Liu JJ, Yeh CT, Chang TC,
Wu CH, Ho YS, Wei PL and Chang YJ: MicroRNA-200a and −200b mediated
hepatocellular carcinoma cell migration through the epithelial to
mesenchymal transition markers. Ann Surg Oncol. 20 (Suppl
3):S360–S368. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang X, Chen X, Wang R, Xiao P, Xu Z, Chen
L, Hang W, Ruan A, Yang H and Zhang X: microRNA-200c modulates the
epithelial-to-mesenchymal transition in human renal cell carcinoma
metastasis. Oncol Rep. 30:643–650. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fidler IJ: The pathogenesis of cancer
metastasis: The ‘seed and soil’ hypothesis revisited. Nat Rev
Cancer. 3:453–458. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Villanueva A, Newell P, Chiang DY,
Friedman SL and Llovet JM: Genomics and signaling pathways in
hepatocellular carcinoma. Semin Liver Dis. 27:55–76. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sun J, Lu H, Wang X and Jin H: MicroRNAs
in hepatocellular carcinoma: Regulation, function, and clinical
implications. ScientificWorldJournal. 2013:9242062013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Farazi TA, Hoell JI, Morozov P and Tuschl
T: MicroRNAs in human cancerMicroRNA Cancer Regulation. Schmitz U,
Wolkenhauer O and Vera J: Springer; Dordrecht: pp. 1–20. 2013,
View Article : Google Scholar
|
|
36
|
Wong CCL, Wong CM, Tung EKK, Au SL, Lee
JM, Poon RT, Man K and Ng IO: The microRNA miR-139 suppresses
metastasis and progression of hepatocellular carcinoma by
down-regulating Rho-kinase 2. Gastroenterology. 140:322–331. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gregory PA, Bert AG, Paterson EL, Barry
SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gibbons DL, Lin W, Creighton CJ, Rizvi ZH,
Gregory PA, Goodall GJ, Thilaganathan N, Du L, Zhang Y,
Pertsemlidis A, et al: Contextual extracellular cues promote tumor
cell EMT and metastasis by regulating miR-200 family expression.
Genes Dev. 23:2140–2151. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ikushima H and Miyazono K: TGFbeta
signalling: A complex web in cancer progression. Nat Rev Cancer.
10:415–424. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yang H, Fang F, Chang R and Yang L:
MicroRNA-140-5p suppresses tumor growth and metastasis by targeting
transforming growth factor β receptor 1 and fibroblast growth
factor 9 in hepatocellular carcinoma. Hepatology. 58:205–217. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Nelson AR, Fingleton B, Rothenberg ML and
Matrisian LM: Matrix metalloproteinases: Biologic activity and
clinical implications. J Clin Oncol. 18:1135–1149. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tang J, Cui J, Chen R, Guo K, Kang X, Li
Y, Gao D, Sun L, Xu C, Chen J, et al: A three-dimensional cell
biology model of human hepatocellular carcinoma in vitro. Tumour
Biol. 32:469–479. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chen R, Cui J, Xu C, Xue T, Guo K, Gao D,
Liu Y, Ye S and Ren Z: The significance of MMP-9 over MMP-2 in HCC
invasiveness and recurrence of hepatocellular carcinoma after
curative resection. Ann Surg Oncol. 19 (Suppl 3):S375–S384. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Bergers G and Benjamin LE: Tumorigenesis
and the angiogenic switch. Nat Rev Cancer. 3:401–410. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zavadil J, Cermak L, Soto-Nieves N and
Böttinger EP: Integration of TGF-beta/Smad and Jagged1/Notch
signalling in epithelial- to-mesenchymal transition. EMBO J.
23:1155–1165. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ding J, Huang S, Wu S, Zhao Y, Liang L,
Yan M, Ge C, Yao J, Chen T, Wan D, et al: Gain of miR-151 on
chromosome 8q24. 3 facilitates tumour cell migration and spreading
through downregulating RhoGDIA. Nat Cell Biol. 12:390–399. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Walsh MF, Ampasala DR, Hatfield J, Vander
Heide R, Suer S, Rishi AK and Basson MD: Transforming growth
factor-β stimulates intestinal epithelial focal adhesion kinase
synthesis via Smad- and p38-dependent mechanisms. Am J Pathol.
173:385–399. 2008. View Article : Google Scholar : PubMed/NCBI
|
